Loading…
InfuSystem Holdings, Inc. is projected to rise to $11.41 by 2027, a +25% move from its current price of $9.14. INFU is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $8.90 | $9.14 | $9.39 | 0.00% |
| Aug 5 | $8.80 | $9.14 | $9.49 | 0.00% |
| Aug 6 | $8.73 | $9.14 | $9.57 | 0.00% |
| Aug 7 | $8.66 | $9.14 | $9.64 | -0.01% |
| Aug 8 | $8.61 | $9.14 | $9.70 | -0.01% |
| Aug 9 | $8.56 | $9.14 | $9.76 | -0.01% |
| Aug 10 | $8.52 | $9.14 | $9.81 | -0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.52 | $9.14 | $9.81 | -0.01% |
| Week 2 | $8.27 | $9.14 | $10.10 | -0.02% |
| Week 3 | $8.09 | $9.14 | $10.33 | -0.03% |
| Week 4 | $7.93 | $9.14 | $10.52 | -0.04% |
| Week 5 | $7.80 | $9.14 | $10.70 | -0.05% |
| Week 6 | $7.68 | $9.13 | $10.86 | -0.06% |
| Week 7 | $7.58 | $9.13 | $11.01 | -0.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
InfuSystem Holdings, Inc. provides infusion pumps and related products and services in the United States and Canada. It operates through two segments: Patient Services and Device Solutions, supplying electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.
It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
InfuSystem operates in the healthcare category, focused on infusion pumps and related services as its core business offerings. This positions the company within a specialized medical equipment and services niche serving oncology clinics and other care settings in the U.S. and Canada.
InfuSystem Holdings, Inc. trades under the symbol INFU. It has a current price of $9.19 and a market capitalization of $185.47M, with a rank of 3622. The stock’s near-term outlook is framed by a forecast that shows a rising average price path from 2026 through 2050, supported by bullish longer-term sentiment for most years.
The 30-day technical backdrop shows modest volatility and defined support and resistance levels.
Forecasts indicate the average price climbs from $9.19 in 2026 to higher levels in following years, with a 2030 average of $17.75 and a 2050 average of $84.04, accompanied by a long-run bullish stance. The predicted maximum prices rise correspondingly, yielding substantial upside potential by 2050.
Near-term dynamics show a 30-day range from $7.67 to $11.02, with sentiment labeled as bullish in the longer horizon and a near-term neutral-to-bullish tone. The implied ROI grows markedly across the forecast, culminating in multi-decade upside.
A major floor 11.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.7% away) — a key level to hold.
The nearest ceiling, 11.2% above — a clean break opens room to run.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key INFU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INFU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.47 | Sell | $9.32 | Sell |
| MA 10 | $9.24 | Sell | $9.31 | Sell |
| MA 20 | $9.34 | Sell | $9.32 | Sell |
| MA 50 | $9.31 | Sell | $9.34 | Sell |
| MA 100 | $9.47 | Sell | $9.30 | Sell |
| MA 200 | $9.25 | Sell | $9.08 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.96 | Neutral |
| Stoch RSI (14) | 27.49 | Neutral |
| CCI (20) | -43.17 | Neutral |
| Williams %R (14) | -75.73 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 1.44 | Buy |
| Bollinger %B (20,2) | 0.36 | Neutral |
| Stochastic %K (14) | 24.27 | Neutral |
| TRIX (15) | -0.03 | Sell |
| Awesome (5,34) | 0.13 | Buy |
| Ultimate (7,14,28) | 53.29 | Neutral |
| Momentum (10) | 0.22 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 9.57 | Sell |
| ADX (14) | 10.95 | Neutral |
| ATR (14) | 0.23 | Info |
The 30-day technical picture is currently bullish. RSI14 sits at 50, with the price moving around the key moving averages SMA50 at $9.32 and SMA200 at $9.25, indicating a price near established support and resistance zones.
Support is identified at $8.75, while resistance sits at $10.16. The 30-day price range spans from a low of $7.67 to a high of $11.02, highlighting a degree of near-term volatility within a defined band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $7.42 | $9.14 | $11.79 | 0% | Neutral | |
| $9.12 | $11.41 | $15.08 | +25% | Bullish | |
| $11.27 | $14.50 | $19.89 | +59% | Bullish | |
| $12.27 | $16.15 | $22.79 | +77% | Bullish | |
| $12.71 | $17.06 | $24.67 | +87% | Bullish | |
| $12.76 | $17.45 | $25.76 | +91% | Bullish | |
| $13.81 | $19.20 | $28.89 | +110% | Bullish | |
| $14.90 | $21.05 | $32.22 | +130% | Bullish | |
| $16.76 | $24.03 | $37.37 | +163% | Bullish | |
| $19.98 | $29.06 | $45.84 | +218% | Bullish | |
| $24.39 | $37.86 | $63.48 | +314% | Bullish | |
| $44.42 | $77.13 | $141.32 | +744% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $7.42 | $9.14 | $11.34 | +0.00% |
| September 2026 | $7.89 | $9.33 | $11.34 | +2.09% |
| October 2026 | $7.67 | $9.13 | $11.21 | -2.17% |
| November 2026 | $7.80 | $9.34 | $11.56 | +2.30% |
| December 2026 | $7.86 | $9.45 | $11.79 | +1.18% |
Click any year to see its month-by-month INFU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect INFU to range from $7.42 to $11.79 through 2026. The $9.14 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The INFU price prediction for 2027 points to an average of $11.41 (low $9.12, high $15.08) — a potential gain of +25% on today's $9.14. Momentum favours further upside here.
In 2028, INFU is projected to trade between $11.27 and $19.89, averaging $14.50 — a potential gain of +59% from today's $9.14. That is up +27% on the projected 2027 average. Buyers look set to stay in control over this stretch.
InfuSystem Holdings, Inc.'s 2029 outlook centres on $16.15, within a $12.27 to $22.79 range. That is up +11% on the projected 2028 average. That marks a +77% change versus current levels. Momentum favours further upside here.
By 2030, INFU could reach as high as $24.67, with a base case around $17.06 and support toward $12.71 — roughly +87% from $9.14. Buyers look set to stay in control over this stretch.
Expect INFU to range from $12.76 to $25.76 through 2031. The $17.45 average target implies a +91% move from current prices. That is up +2% on the projected 2030 average. Momentum favours further upside here.
The INFU price prediction for 2032 points to an average of $19.20 (low $13.81, high $28.89) — a potential gain of +110% on today's $9.14. Buyers look set to stay in control over this stretch.
In 2033, INFU is projected to trade between $14.90 and $32.22, averaging $21.05 — a potential gain of +130% from today's $9.14. That is up +10% on the projected 2032 average. Momentum favours further upside here.
InfuSystem Holdings, Inc.'s 2034 outlook centres on $24.03, within a $16.76 to $37.37 range. That is up +14% on the projected 2033 average. That marks a +163% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, INFU could reach as high as $45.84, with a base case around $29.06 and support toward $19.98 — roughly +218% from $9.14. Momentum favours further upside here.
Expect INFU to range from $24.39 to $63.48 through 2040. The $37.86 average target implies a +314% move from current prices. That is up +30% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The INFU price prediction for 2050 points to an average of $77.13 (low $44.42, high $141.32) — a potential gain of +744% on today's $9.14. Momentum favours further upside here.
Investing $1,000 in INFU today (≈ 109.40919 INFU) could be worth
$8,438.96
+$7,438.96 (+744%) by 2050 · US Dollar
Based on the average projected INFU price of $77.13 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INFUwould be worth at today's price.
$1,000 invested in INFU on Jul 31, 2025 (≈ 178.571432 INFU) would be worth
$1,632.14
+$632.14 (+63.2%) today · 1.63× · US Dollar
Based on a INFU entry price of $5.6 vs. today's $9.14.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $9.12 | $1,002.19 | +0.2% |
| 1 month ago | $10.02 | $912.18 | -8.8% |
| 3 months ago | $10.37 | $881.39 | -11.9% |
| 6 months ago | $8.24 | $1,109.22 | +10.9% |
| 1 year ago | $5.6 | $1,632.14 | +63.2% |
| All time (5.0y) ago | $19.9 | $459.3 | -54.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INFU forecast.
Our base-case forecast reaches $18.00 around 2032.
Implied market cap at $18.00: $363.27M
The multi-year forecast paints a steadily rising path for INFU, with the 2026 average at $9.19 and the 2027 average at $11.69, yielding a 27.2% ROI for 2027. The trajectory continues higher, with 2028 at $15.04 (63.7% ROI) and 2029 at $16.73 (82% ROI), then 2030 at $17.75 (93.1% ROI). The sentiment remains bullish across these years.
Beyond 2030, the forecast shows continued strength: 2031 average $18.28 (99% ROI), 2032 $20.15 (119.3% ROI), 2033 $22.29 (142.5% ROI), 2034 $25.71 (179.8% ROI), and 2035 $31.07 (238% ROI). The long-run horizon extends to 2040 with an average of $41.16 (347.9% ROI) and to 2050 with an average of $84.04 (814.4% ROI). The maximums align with these paths, reaching as high as $25.82 in 2030, $69.65 in 2040, and $155.69 in 2050.
The overall tone remains bullish, though these figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $17.75, with a minimum of $13.15 and a maximum of $25.82. The projected ROI is 93.1% and the sentiment is BULLISH.
Forecasts show positive upside after 2026, with 2027 average $11.69 and ROI 27.2%, 2028 average $15.04 and ROI 63.7%, 2029 average $16.73 and ROI 82%, and 2030 average $17.75 with ROI 93.1%. The longer horizon remains bullish through 2050, with substantial expected upside.
Yes. The maximum forecast by 2050 is $155.69, and the 2050 average is $84.04, indicating that a $100 level is within the forecasted upside by 2050 (2040 max is $69.65).
The current price is $9.19.
The 30-day range is from a low of $7.67 to a high of $11.02.
InfuSystem Holdings, Inc. Community Discussion
0Share your InfuSystem Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.